Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis.
暂无分享，去创建一个
M. Aguilar-Luque | B. Escribano | I. Túnez | F. Gascón | E. Aguera | E. Luque | A. I. Giraldo | F. Sánchez-López | C. Conde | R. Lillo | C. Bahamonde | A. H. Cruz